Frontlight ResearchEarly access
Trial site
Polabska zdravotni s.r.o.
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Atrial fibrillation2 trials
- Stroke1 trial
- Phase
- Phase 21 trial
- Phase 31 trial
- Status
- Active, not recruiting2 trials
- Lead sponsor
- Anthos Therapeutics, Inc.2 trials
Running trials
Recruiting
Active, not recruiting
Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026